Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overall Response Rate”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Ended earlyNCT00595985
What this trial is testing

Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 5
Testing effectiveness (Phase 2)Study completedNCT00699881
What this trial is testing

Study of Cetuximab to Treat Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 61
Testing effectiveness (Phase 2)Looking for participantsNCT07448142
What this trial is testing

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591831
What this trial is testing

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Recurrent Ovarian CancerFallopian Tube CancersEpithelial Ovarian Cancer+1 more
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT05673967
What this trial is testing

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 62
Not applicableLooking for participantsNCT06531681
What this trial is testing

Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

Who this might be right for
Overall Response RateOncologyRadiation Toxicity+1 more
The Second Affiliated Hospital of Hainan Medical University 3,000
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04215146
What this trial is testing

Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Who this might be right for
Breast Cancer Metastatic
Oncolytics Biotech 48
Testing effectiveness (Phase 2)Ended earlyNCT02504892
What this trial is testing

Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer

Who this might be right for
Renal CancerBirt-Hogg-Dube Syndrome
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)UnknownNCT00839111
What this trial is testing

Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment

Who this might be right for
Colorectal Neoplasms
Fudan University 43
Testing effectiveness (Phase 2)Looking for participantsNCT06530576
What this trial is testing

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 48
Testing effectiveness (Phase 2)Study completedNCT00253370
What this trial is testing

Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionMetastatic Gastric CancerAdvanced Unresectable Gastric Cancer
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)UnknownNCT04899427
What this trial is testing

Phase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Peking Union Medical College Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07090525
What this trial is testing

Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

Who this might be right for
Overall Response Rate
Qingdao Central Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04896658
What this trial is testing

Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
University of Maryland, Baltimore 10
Testing effectiveness (Phase 2)Study completedNCT00595972
What this trial is testing

Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 25
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Testing effectiveness (Phase 2)Study completedNCT01893372
What this trial is testing

Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT02008006
What this trial is testing

BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)

Who this might be right for
Follicular Lymphoma
Centre Leon Berard 21
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Load More Results